# Ecolab Inc.: Form 10-Q for the period ended Mar 31, 2020

- Company: [Ecolab Inc.](/companies/ecl.md) (CIK 31462)
- Form: 10-Q
- Filed: 2020-05-07
- Accepted by EDGAR: May 7, 2020, 20:07 ET
- Period: 2020-03-31
- Accession: 0001558370-20-005691
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/31462/000155837020005691/ecl-20200507x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/31462/000155837020005691/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $3.58bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $2.12bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $1.01bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | $397.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $52.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | $74.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | $290.2m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | $0.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-01-01 to 2020-03-31 | $0.98 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-01-01 to 2020-03-31 | 292,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | $371.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-01-01 to 2020-03-31 | $160.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2020-01-01 to 2020-03-31 | $145.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2020-01-01 to 2020-03-31 | $95.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-03-31 | $1.66bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $6.44bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $22.34bn | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $4.26bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $13.48bn | us-gaap:Liabilities |
| Current portion of debt | at 2020-03-31 | $1.04bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2020-03-31 | $8.82bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2020-03-31 | 289,201,752 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 77,466 characters.

The following management discussion and analysis (“MD&A”) provides information we believe is useful in understanding our operating results, cash flows and financial condition. We provide quantitative information about the material sales drivers including the impact of changes in volume and pricing and the effect of acquisitions and changes in foreign currency at the corporate and reportable segment level. We also provide quantitative information regarding special (gains) and charges, discrete tax items and other significant factors we believe are useful for understanding our results. Such quantitative drivers are supported by comments meant to be qualitative in nature. Qualitative factors are generally ordered based on estimated significance.

The MD&A should be read in conjunction with both the unaudited consolidated financial information and related notes included in this Form 10-Q, and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2019. This discussion contains various Non-GAAP Financial Measures and also contains various Forward-Looking Statements within the meaning of the Private Securities Litigation Reform Act of 1995. We refer readers to the statements entitled “Non-GAAP Financial Measures” and “Forward-Looking Statements” located at the end of Part I of this report.

### Comparability of Results

### Fixed Currency Foreign Exchange Rates

Management evaluates the sales and operating income performance of our non-U.S. dollar functional currency international operations based on fixed currency exchange rates, which eliminate the impact of exchange rate fluctuations on our international operations. Fixed currency amounts are updated annually at the beginning of each year based on translation into U.S. dollars at foreign currency exchange rates established by management, with all periods presented using such rates. Public currency rate data provided within the “Segment Performance” section of this MD&A reflect amounts translated at actual public average rates of exchange prevailing during the corresponding period and is provided for informational purposes only.

### Comparability of Reportable Segments

Effective in the first quarter of 2020, and in anticipation of the separation of our Upstream Energy business under ChampionX Holding Inc. (ChampionX), a wholly owned subsidiary of Ecolab formed for the purpose of holding the Upstream Energy Business, we created the Upstream and Downstream operating segments from the Global Energy operating segment, which was also a reportable segment. Segment information reflects the elimination of the Global Energy reportable segment and creation of the Downstream operating segment and the Upstream operating segment, which are reported in the Global Industrial reportable segment and newly established Upstream Energy reportable segment, respectively. Also, in the first quarter of 2020, we announced leadership changes which allow for shared oversight and focus on the Healthcare and Life Sciences operating segments and established the Global Healthcare and Life Sciences reportable segment. This segment is comprised of the Healthcare operating segment which was previously aggregated in the Global Institutional reportable segment and the Life Sciences operating segment which was previously aggregated in the Global Industrial reportable segment. Additionally, the Textile Care operating segment being reported in Other, which had previously been aggregated in the Global Industrial reportable segment. The Company made other immaterial changes, including the movement of certain customers and cost allocations between reportable segments.

### Impact of Acquisitions and Divestitures

Acquisition adjusted growth rates exclude the results of our acquired businesses from the first twelve months post acquisition and exclude the results of our divested businesses from the twelve months prior to divestiture.

### ChampionX Separation

On December 18, 2019, the Company entered into definitive agreements with ChampionX and Apergy Corporation (Apergy) pursuant to which the Company will separate the Upstream Energy business and combine it with Apergy in a tax-efficient Reverse Morris Trust transaction.

The transaction will occur in a multi-step process pursuant to which, prior to the merger between ChampionX and Apergy, the Company will transfer certain assets, liabilities and entities to ChampionX or its subsidiaries. In exchange, the Company will receive shares of ChampionX common stock and a cash payment, and all shares of ChampionX common stock will be distributed to Ecolab stockholders in an exchange offer. Under the terms of the exchange offer, Ecolab stockholders have to option to exchange all, some or none of their shares of Ecolab comment stock for shares of ChampionX common stock. If the exchange offer is fully subscribed and at the conclusion of this exchange, the shares of ChampionX common stock will immediately be converted into shares of Apergy common stock as part of the Merger. All shares of Ecolab common stock that will be tendered and accepted in the exchange will be retired and reduce the number of common stock outstanding.

As a result of and immediately following the Transactions, ChampionX stockholders will own, in the aggregate, approximately 62% of the issued and outstanding Apergy common stock on a fully diluted basis and Apergy stock and equity holders will own, in the aggregate, approximately 38% of the issued and outstanding Apergy common stock on a fully diluted basis (127 million shares). Ecolab stockholders that do not participate in this Exchange Offer will retain the shares of Ecolab common stock that they held prior to the Merger.

In connection with the transaction, ChampionX will enter into a credit agreement with respect to a $537 million senior secured term loan credit facility to finance the one-time special cash payment to Ecolab and will otherwise pay certain expenses in connection with the transaction. The Company intends to use the proceeds to repay debt, pay dividends, repurchase its stock, or a combination thereof.

Ecolab will account for this transaction as a sale and will recognize a gain or loss based on the excess or deficit of consideration received over the carrying value of ChampionX. Consideration received includes a one-time special cash payment (net of cash included on the opening ChampionX balance sheet) from ChampionX and the fair value of the shares of Ecolab common stock tendered and retired as part of the exchange. The cash consideration Ecolab will receive of $.5 billion is less than the carrying value of ChampionX of about $3.7 billion. As a result, the gain or loss calculated by subtracting the remaining book value of ChampionX from the non-cash share consideration will be a non-cash gain or loss.

The fair value of the Ecolab common stock tendered in the exchange less stock-based equity is based on the 62% (approximately 122.6 million shares) of the outstanding stock of Apergy multiplied by the value of the volume-weighted average Apergy share price of the last three full trading days ending on the expiration date of the exchange offer. As of March 31, 2020, and the average during the quarter-ended March 31, 2020, the price of Apergy’s stock was $5.75 and $21.00, respectively. Utilizing the $5.75 and the $21.00 Apergy stock price to calculate the fair value of the non-cash Ecolab common stock consideration yields a non-cash loss of ($2.5 billion) and ($0.8 billion), respectively.

### CRITICAL ACCOUNTING ESTIMATES

In our report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on February 28, 2020, we disclosed our Critical Accounting Estimates. The discussion below provides an update to the Critical Accounting Estimates and should be read together with the full list of Critical Accounting Estimates set forth in the aforementioned Form 10-K.

### Goodwill

We had total goodwill of $7.2 billion and $7.3 billion as of March 31, 2020 and December 31, 2019, respectively. Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in a business combination. Our reporting units are our operating segments. We assess goodwill for impairment on an annual basis during the second quarter. If circumstances change significantly, we would complete an interim goodwill assessment of a reporting unit’s goodwill prior to its next annual assessment.

During the first quarter of 2020, oil prices decreased significantly due to decreased demand following the coronavirus outbreak and falling prices stemming from a lack of consensus among OPEC member nations on production reductions and oil producing nations’ response to reduced prices. The culmination of these events has created instability in the oil and gas industry and resulted in sharp declines in the stock prices of most industry participants. In addition, the uncertainty related to oil demand continues to have a significant impact on the investment and operating plans of Upstream Energy customers. As a result, we performed an interim goodwill impairment assessment for the Upstream Energy reporting unit as of March 31, 2020.

We used the discounted cash flow method to determine the fair value of the Upstream Energy reporting unit. Fair value determinations require considerable judgment and are sensitive to changes in underlying assumptions, estimates, and market factors. Included in the estimated fair value of the Upstream Energy reporting unit are assumptions and estimates regarding Upstream Energy’s future projections, as well as industry projections. These assumptions and estimates include estimated future growth rates, the discount rate, the terminal growth rate, and other market factors. Development of these assumption included significant observable market information and considered current market conditions as of March 31, 2020.

Based on the analysis performed, we concluded that the fair value of the Upstream Energy reporting unit exceeded the carrying value by more than 30%. If current expectations of future sales growth and margins are not met, if market factors outside our control result in changes to valuation assumption, most notably the discount rate, or if management’s expectations or plans otherwise change, then the Upstream Energy reporting unit may become impaired in the future. Recognizing the volatility of current markets, we completed various sensitivities. An increase in the discount rate of 1.0 percentage point, holding all other assumptions constant, would continue to result in a fair value that exceeds the carrying value. Similarly, a decrease in Upstream Energy’s projected terminal growth rate by 1.0 percentage point would also result in a fair value that exceeds the carrying value, when holding all other assumption constant. We also considered the implied value of the Upstream Energy reporting unit based on the ChampionX separation transaction (refer to ChampionX Separation above for more information). In each of these scenarios, the fair value of the Upstream Energy reporting unit would be above its carrying amount as of March 31, 2020 and the Upstream Energy reporting unit’s goodwill would not be impaired.

### OVERVIEW OF THE FIRST QUARTER ENDED MARCH 31, 2020

### Sales Performance

When comparing first quarter 2020 against first quarter 2019, sales performance was as follows:

- Reported net sales increased 2% to $3,581 million, fixed currency sales and acquisition adjusted fixed currency sales increased 3% and 2%, respectively.
- Fixed currency sales for our Global Industrial segment increased 3% to $1,444 million, acquisition adjusted fixed currency sales increased 3%, led by strong growth in Food & Beverage and good gains in Downstream and Paper.
- Fixed currency sales for our Global Institutional segment increased 5% to $1,072 million. Acquisition adjusted fixed currency sales increased 4%, led by very strong growth in Specialty.
- Fixed currency sales for our Global Healthcare and Life Sciences segment increased 8% to $246 million. Acquisition adjusted fixed currency sales also increased 4%, led by strong Life Sciences results.
- Fixed currency sales for our Upstream Energy segment decreased 3% to $563 million. Acquisition adjusted fixed currency sales also decreased 3%.
- Fixed currency sales and acquisition adjusted fixed currency sales for Other sales increased 1% to $278 million, led by modest growth in Pest Elimination.

### Financial Performance

When comparing first quarter 2020 against first quarter 2019, our financial performance was as follows:

- Reported operating income increased 8% to $397 million. Excluding the impact of special (gains) and charges from both 2020 and 2019 reported results, adjusted operating income increased 12% and our adjusted fixed currency operating income increased 12%.
- Net income attributable to Ecolab decreased 4% to $283 million. Excluding the impact of special (gains) and charges and discrete tax items from both 2020 and 2019 reported results, our adjusted net income attributable to Ecolab increased 10%.
- Reported diluted EPS of $0.97 decreased 4%. Excluding the impact of special (gains) and charges and discrete tax items from both 2020 and 2019 reported results, adjusted diluted EPS increased 10% to $1.13 in the first quarter of 2020.
- Our reported tax rate was 20.3% during the first quarter of 2020, compared to 11.4% during the first quarter of 2019. Excluding the tax rate impact of special (gains) and charges and discrete tax items from both 2020 and 2019 results, our adjusted tax rate was 20.6% during the first quarter of 2020 and 2019.

### RESULTS OF OPERATIONS

### Net Sales

| ​ ​ ​ (millions) | ​ ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ ​ | ​ 2019 | ​ | ​ ​ | ​ ​ Change | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- | --- |
| Product and equipment sales | ​ | **​** | **$2,930.0** | **​** | ​ | ​ | $2,886.3 | ​ | **​** **​** | **​** |
| Service and lease sales | ​ | **​** | **651.4** | **​** | ​ | ​ | 619.1 | ​ | **​** **​** | **​** |
| Reported GAAP net sales | ​ | **​** | **$3,581.4** | **​** | ​ | ​ | $3,505.4 | ​ | **2%** | **​** |
| Effect of foreign currency translation | ​ |  | **21.6** | **​** | ​ | ​ | (4.4) | ​ | **​** **​** | **​** |
| Non-GAAP fixed currency sales | ​ | **​** | **$3,603.0** | **​** | ​ | ​ | $3,501.0 | ​ | **3%** | **​** |
| ​ | ​ | **​** | **​** | **​** | ​ | ​ | ​ | ​ | **​** ​ | ​ |

Product and sold equipment revenue is generated from providing cleaning, sanitizing, water and energy products or selling equipment used in combination with specialized products. Service and lease equipment revenue is generated from providing services or leasing equipment to customers. All of our sales are subject to the same economic conditions.

The percentage components of the period-over-period 2020 sales change are shown below:

| ​ ​ ​ ​ ​ ​ ​ ​ (percent) | ​ ​ First Quarter Ended March 31 2020 |
| --- | ---: |
| Volume | **1%** |
| Price changes | **2** |
| Acquisition adjusted fixed currency sales change | **2** |
| Acquisitions and divestitures | **1** |
| Fixed currency sales change | **3** |
| Foreign currency translation | **(1)** |
| Reported GAAP net sales change | **2%** |

Amounts do not necessarily sum due to rounding.

### Cost of Sales (“COS”) and Gross Profit Margin

| ​ ​ ​ ​ ​ (millions/percent) | ​ First Quarter Ended March 31 2020 COS | ​ | ​ | ​ ​ | ​ ​ Gross Margin | ​ ​ ​ ​ | ​ 2019 COS | ​ | ​ | ​ ​ | ​ ​ Gross Margin |
| --- | --- | ---: | --- | --- | --- | --- | --- | ---: | --- | --- | --- |
| Product and equipment cost of sales | ​ | **$1,715.9** | ​ | ​ | **​** **​** | ​ | ​ | $1,710.0 | ​ | ​ | ​ ​ |
| Service and lease cost of sales | ​ | **400.9** | ​ | ​ | **​** **​** | ​ | ​ | 379.6 | ​ | ​ | ​ ​ |
| Reported GAAP COS and gross margin | ​ | **$2,116.8** | ​ | ​ | **40.9%** | ​ | ​ | $2,089.6 | ​ | ​ | 40.4% |
| Special (gains) and charges | ​ | **9.1** | ​ |  | **​** **​** | ​ | ​ | 3.6 | ​ |  | ​ ​ |
| Non-GAAP adjusted COS and gross margin | **​** | **$2,107.7** | ​ | ​ | **41.1%** | ​ | ​ | $2,086.0 | ​ | ​ | 40.5% |

Our COS and corresponding gross profit margin (“gross margin”) are shown in the table above. Gross margin is defined as net sales less cost of sales divided by net sales.

Our reported gross margin was 40.9% and 40.4% for the first quarter of 2020 and 2019, respectively. Special (gains) and charges included in items impacting COS are shown within the “Special (Gains) and Charges” table on page 35.

Excluding the impact of special (gains) and charges within COS, first quarter 2020 and 2019 adjusted gross margin was 41.1% and 40.5%, respectively.

Our adjusted gross margin increased when comparing the first quarter of 2020 comparable periods of 2019, which was driven primarily by increased pricing and lower delivered product costs that were partially offset by other cost increases.

### Selling, General and Administrative Expense

Selling, general and administrative (“SG&A”) expenses as a percentage of sales were 28.3% for the first quarter of 2020 compared to 28.8% in 2019. The decreased SG&A ratio to sales in the first quarter of 2020 was driven primarily by cost savings initiatives and volume growth, which more than offset investments in the business.

### Special (Gains) and Charges

Special (gains) and charges reported on the Consolidated Statement of Income include the following items:

| ​ ​ ​ ​ (millions) Cost of sales | ​ ​ ​ ​ ​ | ​ ​ First Quarter Ended March 31 2020 ​ | ​ ​ ​ | ​ ​ ​ | ​ ​ ​ ​ | ​ ​ 2019 ​ | ​ ​ ​ | ​ ​ ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- |
| Restructuring activities | ​ | **​** | **3.0** | ​ | ​ | ​ | 3.4 | ​ |
| Acquisition and integration activities | ​ | **​** | **0.4** | ​ | ​ | ​ | 0.2 | ​ |
| Other | ​ | **​** | **5.7** | ​ | ​ | ​ | - | ​ |
| Cost of sales subtotal | ​ | **​** | **9.1** | ​ | ​ | ​ | 3.6 | ​ |
| ​ | ​ | **​** | **​** | ​ | ​ | ​ | ​ | ​ |
| Special (gains) and charges | ​ | **​** | **​** | ​ | ​ | ​ | ​ | ​ |
| Restructuring activities | ​ | **​** | **4.3** | ​ | ​ | ​ | 37.1 | ​ |
| ChampionX separation | ​ | **​** | **36.6** | ​ | ​ | ​ | 4.3 | ​ |
| Acquisition and integration activities | ​ | **​** | **5.4** | ​ | ​ | ​ | 2.5 | ​ |
| Other | ​ | **​** | **6.1** | ​ | ​ | ​ | (3.6) | ​ |
| Special (gains) and charges subtotal | ​ | **​** | **52.4** | ​ | ​ | ​ | 40.3 | ​ |
| ​ | ​ | **​** | **​** | ​ | ​ | ​ | ​ | ​ |
| Operating income subtotal | ​ | **​** | **61.5** | ​ | ​ | ​ | 43.9 | ​ |
| ​ | ​ | **​** | **​** | ​ | ​ | ​ | ​ | ​ |
| Interest expense, net | ​ | **​** | **-** | ​ | ​ | ​ | 0.2 | ​ |
| Total special (gains) and charges | ​ | **​** | **$61.5** | **​** | ​ | ​ | $44.1 | ​ |

For segment reporting purposes, special (gains) and charges are not allocated to reportable segments, which is consistent with our internal management reporting.

### Restructuring activities

Restructuring activities are primarily related to Accelerate 2020 (described below). These activities have been included as a component of cost of sales and special (gains) and charges on the Consolidated Statement of Income. Restructuring liabilities have been classified as a component of other current and other noncurrent liabilities on the Consolidated Balance Sheet.

#### Accelerate 2020

During the third quarter of 2018, we formally commenced a restructuring plan Accelerate 2020 (“the Plan”), to leverage technology and system investments and organizational changes. During the first quarter of 2019, we raised our goals for the Plan to further simplify and automate processes and tasks, reduce complexity and management layers, consolidated facilitates and focus on key long-term growth areas by further leveraging technology and structural improvements. We expect that the restructuring activities will be completed by the end of 2020, with total anticipated costs of $260 million ($200 million after tax), or $0.68 per diluted share, over this period of time. Costs are expected to be primarily cash expenditures for severance costs and some facility closure costs relating to team reorganizations. Actual costs may vary from these estimates depending on actions taken.

We recorded restructuring charges of $6.4 million ($5.4 million after tax), or $0.02 per diluted share in the first quarter of 2020. The liability related to the Plan was $87.2 million as of the end of the first quarter of 2020. We have recorded $247.6 million ($189.4 million after tax), or $0.65 per diluted share, of cumulative restructuring charges under the Plan. The majority of the pretax charges represent net cash expenditures which are expected to be paid over a period of a few months to several quarters and continues to be funded from operating activities.

The Plan has delivered $159 million of cumulative cost savings with estimated annual cost savings of $325 million by 2021.

#### Other Restructuring Activities

During the first quarter of 2020, we incurred restructuring charges of $0.9 million ($0.7 million after tax), or less than $0.01 per diluted share related to an immaterial restructuring plan. The charges primarily related to severance. Prior to 2018, we engaged in a number of restructuring plans. During the first quarter of 2020 and 2019, net restructuring charges related to prior year plans were minimal. The restructuring liability balance for all plans commencing prior to 2018 was $7.4 million and $7.7 million as of March 31, 2020 and December 31, 2019, respectively. The reduction in liability was driven primarily by severance payments. The remaining liability is expected to be paid over a period of a few months to several quarters and will continue to be funded from operating activities.

Cash payments during 2020 related to all other restructuring plans excluding Accelerate 2020 were $0.4 million.

### ChampionX Separation

On December 18, 2019, the Company entered into definitive agreements with ChampionX and Apergy pursuant to which the Company will separate the Upstream Energy business and combine it with Apergy in a tax-efficient Reverse Morris Trust transaction. The charges reported during the first quarter of 2020 and 2019 in special (gains) and charges on the Consolidated Statement of Income include $36.6 million ($31.8 million after tax) or $0.11 per diluted share and $4.3 million ($3.3 million after tax) or $0.01 per diluted share, respectively. The charges are primarily related to professional fees to support the separation.

### Acquisition and integration related costs

Acquisition and integration costs reported in special (gains) and charges on the Consolidated Statement of Income include $5.4 million ($3.6 million after tax) or $0.01 per diluted share and $2.5 million ($1.8 million after tax) or $0.01 per diluted share, in the first quarter of 2020 and 2019, respectively. Charges are related to Bioquell PLC (“Bioquell”) and the Laboratoires Anios (“Anios”) acquisitions and consist of integration costs, advisory and legal fees. Acquisition and integration costs reported in product and equipment cost of sales of $0.4 million ($0.3 million after tax) or less than $0.01 per diluted share and $0.2 million ($0.1 million after tax) or less than $0.01 per diluted share, in the first quarter of 2020 and 2019, respectively, on the Consolidated Statement of Income relate to severance related to the closure of a facility. We also incurred $0.2 million ($0.1 million after tax) or less than $0.01 per diluted share, of interest expense in the first quarter of 2019.

### Other

During the first quarter of 2020, we recorded special charges of $5.7 million ($3.8 million after tax) or $0.01 per diluted share recorded in product and equipment cost of sales relates to a Healthcare product recall in Europe. Other special charges of $6.1 million ($4.6 million after tax) or $0.02 per diluted share recorded in the first quarter of 2020 relate primarily to legal charges.

During the first quarter of 2019, we recorded other special charges of $3.6 million (14.3 million after tax) or $0.01 per diluted share, which primarily related to a litigation settlement which was offset with other legal charges.

### Operating Income and Operating Income Margin

| ​ ​ ​ ​ (millions) | ​ ​ ​ ​ ​ | ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ First Quarter Ended March 31 2020 2019 ​ | ​ ​ ​ ​ Change |
| --- | --- | --- | --- |
| Reported GAAP operating income | ​ | **​** **$397.2** **​** ​ ​ $367.2 ​ | **8%** |
| Special (gains) and charges | ​ | **61.5** **​** ​ 43.9 ​ | ​ ​ |
| Non-GAAP adjusted operating income | ​ | **458.7** **​** ​ 411.1 ​ | **12%** |
| Effect of foreign currency translation | ​ | **2.9** **​** ​ (0.5) ​ | ​ ​ |
| Non-GAAP adjusted fixed currency operating income | ​ | **​** **$461.6** **​** ​ ​ $410.6 ​ | **12%** |
| ​ | ​ | ​ **​** **​** ​ ​ ​ ​ | ​ ​ |
| ​ | ​ | First Quarter Ended | ​ ​ |
| ​ | ​ | March 31 | ​ ​ |
| (percent) | ​ | **2020** ​ 2019 | ​ ​ |
| Reported GAAP operating income margin | ​ | **​** **11.1%** ​ ​ 10.5% | ​ ​ |
| Non-GAAP adjusted operating income margin | ​ | **​** **12.8%** ​ ​ 11.7% | ​ ​ |
| Non-GAAP adjusted fixed currency operating income margin | ​ | **​** **12.8%** ​ ​ 11.7% | ​ ​ |

Our operating income and corresponding operating income margin are shown in the previous tables. Operating income margin is defined as operating income divided by net sales.

Our reported operating income increased 8% in the first quarter of 2020, versus the comparable periods of 2019. Our reported operating income for 2020 and 2019 was impacted by special (gains) and charges; excluding the impact of special (gains) and charges from 2020 and 2019 reported results, our adjusted operating income increased 12% in the first quarter of 2020.

As shown in the previous table, foreign currency had a minimal impact on adjusted operating income growth for the first quarter of 2020. Foreign currency had a 3% impact on adjusted operating income growth for the first quarter of 2019.

### Other (Income) Expense

Other income was $15.2 million and $21.2 million in the first quarter of 2020 and 2019, respectively. Other income decreased in the first quarter of 2020 compared to 2019, reflecting the return on pension assets and non-service costs of our pension obligations.

### Interest Expense, Net

| ​ ​ ​ (millions) | ​ ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ | ​ 2019 | ​ | ​ ​ ​ | ​ ​ ​ ​ Change | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | ---: | --- |
| Reported GAAP interest expense, net | ​ | **​** | **$48.1** | **​** | ​ | ​ | $49.4 | ​ | **(3)%** | ​ |
| Special (gains) and charges | ​ | **​** | **-** | **​** | ​ |  | 0.2 | ​ | ​ ​ | ​ |
| Non-GAAP adjusted interest expense, net | ​ | **​** | **$48.1** | **​** | ​ | ​ | $49.2 | ​ | **(2)%** | ​ |

Reported net interest expense was $48.1 million and $49.4 million in the first quarter of 2020 and 2019, respectively. The decrease in net interest expense when comparing 2020 against 2019 was driven primarily by lower average interest rates and lower outstanding debt, partially offset by lower interest income.

### Provision for Income Taxes

The following table provides a summary of our tax rate:

| ​ ​ ​ (percent) ​ | ​ ​ ​ ​ | ​ ​ First Quarter Ended March 31 2020 ​ ​ | ​ ​ ​ | ​ ​ 2019 ​ ​ | ​ ​ ​ ​ |
| --- | --- | ---: | --- | ---: | --- |
| Reported GAAP tax rate | **​** | 20.3% | **​** | 11.4% | **​** |
| Tax rate impact of: | ​ | ​ ​ | ​ | ​ ​ | ​ |
| The Tax Act | ​ | **-** ​ | ​ | 1.3 ​ | ​ |
| Special (gains) and charges |  | **(0.2)** **​** | **​** | 2.0 ​ | **​** |
| Discrete tax items |  | **0.5** **​** | **​** | 5.9 ​ | **​** |
| Non-GAAP adjusted tax rate |  | **20.6%** | **​** | 20.6% |  |

Our reported tax rate was 20.3% and 11.4% for the first quarter of 2020 and 2019, respectively. The change in our tax rate for the first quarter of 2020 versus the comparable period of 2019 was driven primarily by discrete tax items and special (gains) and charges. The tax impact of special (gains) and charges and discrete tax items will likely continue to impact comparability of our reported tax rate in the future as amounts included in special (gains) and charges are derived from tax jurisdictions with rates that vary from our effective tax rate, and discrete tax items are not necessarily consistent across periods. Our tax rate is based on our interpretations of existing tax rules; potential future guidance including regulations not yet issued could impact the future tax rate.

We recognized total net tax benefits related to discrete tax items of $2.3 million in the first quarter of 2020. Share-based compensation excess tax benefit contributed $23.4 million in the first quarter of 2020. We also recognized expense related to friction costs associated with ChampionX separation activity of $18.8 million. Additionally, we recognized expense of $5.8 million related to foreign and U.S. changes in estimates. The remaining discrete benefit of $3.5 million was due to reserve released during the quarter.

We recognized total net benefit related to discrete tax items of $27.7 million in the first quarter of 2019. Share-based compensation excess tax benefit contributed $18.7 million. We also recognized a $5.1 million benefit due to issuance of technical guidance during the quarter related to the one-time transition tax imposed by the Tax Cuts and Jobs Act (the “Act”). The remaining discrete benefit was primarily related to changes in tax rates in non-U.S. jurisdictions.

### Net Income Attributable to Ecolab

| ​ ​ ​ (millions) | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ | ​ 2019 | ​ | ​ | ​ ​ Change | ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- | --- |
| Reported GAAP net income attributable to Ecolab | **​** | **​** | **$283.4** | **​** | ​ | ​ | $296.5 | **​** | **(4)%** | **​** |
| Adjustments: | ​ | ​ | **​** | **​** | ​ | ​ | ​ | ​ | **​** ​ | ​ |
| Special (gains) and charges, after tax | ​ |  | **50.2** | **​** | ​ | ​ | 31.5 | ​ | **​** ​ | ​ |
| Discrete tax net expense (benefit) | ​ |  | **(2.3)** | **​** | ​ | ​ | (27.7) | ​ | **​** ​ | ​ |
| Non-GAAP adjusted net income attributable to Ecolab | ​ | **​** | **$331.3** | **​** | ​ | ​ | $300.3 | ​ | **10%** | ​ |

### Diluted EPS

| ​ ​ ​ (dollars) | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ | ​ 2019 | ​ | ​ | ​ ​ Change | ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- | --- |
| Reported GAAP diluted EPS | **​** | **​** | **$0.97** | **​** | ​ | ​ | $ 1.01 | **​** | **(4)%** | **​** |
| Adjustments: | ​ | ​ | **​** | ​ | ​ | ​ | ​ | ​ | ​ ​ | ​ |
| Special (gains) and charges | **​** |  | **0.17** | **​** | ​ | ​ | 0.11 | ​ | ​ ​ | **​** |
| Discrete tax net expense (benefit) | ​ |  | **(0.01)** | **​** | ​ | ​ | (0.09) | ​ | ​ ​ | ​ |
| Non-GAAP adjusted diluted EPS | ​ | **​** | **$1.13** | **​** | ​ | ​ | $ 1.03 | ​ | **10%** | ​ |

Per share amounts in the above tables do not necessary sum due to rounding.

Currency translation had an unfavorable impact of approximately $0.01 per share on diluted EPS for the first quarter of 2020, when compared to the first quarter of 2019.

### SEGMENT PERFORMANCE

The non-U.S. dollar functional international amounts included within our reportable segments are based on translation into U.S. dollars at the fixed currency exchange rates used by management for 2020. The difference between the fixed currency exchange rates and the actual currency exchange rates is reported as “effect of foreign currency translation” in the following tables. All other accounting policies of the reportable segments are consistent with U.S. GAAP and the accounting policies described in Note 2 of our Annual Report on Form 10-K for the year ended December 31, 2019. Additional information about our reportable segments is included in Note 15.

Fixed currency net sales and operating income for the first quarter of 2020 and 2019 for our reportable segments are shown in the following tables.

| ​ Net Sales ​ (millions) | ​ ​ ​ | ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ First Quarter Ended March 31 2020 2019 ​ ​ Change | ​ ​ ​ |
| --- | --- | --- | --- |
| Global Industrial | **​** | **​** **$1,444.0** **​** ​ $1,397.4 ​ **3%** | **​** |
| Global Institutional |  | **​** **1,072.3** **​** ​ 1,020.2 ​ ​ **5** ​ |  |
| Global Healthcare and Life Sciences | **​** | **​** **246.2** **​** ​ ​ 227.0 ​ ​ **8** ​ | **​** |
| Upstream Energy | **​** | **​** **562.7** **​** ​ ​ 581.7 ​ ​ **(3)** ​ | **​** |
| Other |  | **​** **277.8** **​** ​ 274.7 ​ ​ **1** ​ |  |
| Subtotal at fixed currency |  | **​** **3,603.0** **​** ​ 3,501.0 ​ ​ **3** ​ |  |
| Effect of foreign currency translation |  | **​** **(21.6)** **​** ​ 4.4 ​ ​ **​** ​ |  |
| Consolidated reported GAAP net sales |  | **​** **$3,581.4** **​** ​ ​ $3,505.4 ​ ​ **2%** |  |
| ​ | ​ | ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ | ​ |
| **Operating Income** | **​** | First Quarter Ended | ​ |
| ​ | **​** | March 31 | ​ |
| (millions) | ​ | **2020** 2019 ​ ​ **Change** | ​ |
| Global Industrial |  | **$226.9** **​** ​ $181.2 **​** **25%** | ​ |
| Global Institutional |  | **​** **183.5** **​** ​ 176.2 **​** **4** ​ | ​ |
| Global Healthcare and Life Sciences | **​** | **​** **25.6** **​** ​ ​ 27.3 **​** **​** **(6)** ​ | ​ |
| Upstream Energy | **​** | **​** **39.0** **​** ​ ​ 36.5 **​** **​** **7** ​ | ​ |
| Other |  | **​** **25.3** **​** ​ 28.9 **​** **(12)** ​ | ​ |
| Corporate |  | **​** **(100.2)** **​** ​ (83.4) ​ ​ ​ ​ | ​ |
| Subtotal at fixed currency |  | **​** **400.1** **​** ​ 366.7 **​** **9** ​ | ​ |
| Effect of foreign currency translation |  | **​** **(2.9)** **​** ​ 0.5 ​ ​ **​** ​ | ​ |
| Consolidated reported GAAP operating income |  | **$397.2** **​** ​ ​ $367.2 **​** **8%** | ​ |

The following tables reconcile the impact of acquisitions and divestitures within our reportable segments.

| ​ ​ ​ Net Sales (millions) | ​ ​ ​ ​ | ​ ​ ​ ​ ​ First Quarter Ended March 31 2020 Fixed Currency ​ Impact of Acquisitions and Divestitures ​ Acquisition Adjusted | ​ ​ ​ | ​ ​ ​ ​ ​ 2019 Fixed Currency ​ Impact of Acquisitions and Divestitures ​ Acquisition Adjusted |
| --- | --- | ---: | --- | ---: |
| Global Industrial | **​** | **$1,444.0** **​** **-** **​** **$1,444.0** | ​ | $1,397.4 ​ - ​ $1,397.4 |
| Global Institutional |  | **1,072.3** **​** **(14.1)** **​** **1,058.2** | ​ | 1,020.2 ​ - ​ 1,020.2 |
| Global Healthcare and Life Sciences | **​** | **246.2** **​** **(9.5)** **​** **236.7** | ​ | 227.0 ​ - ​ 227.0 |
| Upstream Energy | **​** | **562.7** **​** **-** **​** **562.7** | ​ | 581.7 ​ - ​ 581.7 |
| Other |  | **277.8** **​** **(0.4)** **​** **277.4** | ​ | 274.7 ​ - ​ 274.7 |
| Subtotal at fixed currency |  | **3,603.0** **​** **(24.0)** **​** **3,579.0** | ​ | 3,501.0 ​ - ​ 3,501.0 |
| Effect of foreign currency translation |  | **(21.6)** **​** ​ **​** ​ | ​ | 4.4 ​ ​ ​ ​ |
| Total reported net sales |  | **$3,581.4** **​** ​ **​** ​ | ​ | $3,505.4 ​ ​ ​ ​ |
| ​ | ​ | ​ ​ ​ ​ ​ | ​ | ​ ​ ​ ​ ​ |
| **Operating Income** | **​** | **2020** | ​ | 2019 |
| (millions) |  | Fixed Currency ​ Impact of Acquisitions and Divestitures ​ Acquisition Adjusted | ​ | Fixed Currency ​ Impact of Acquisitions and Divestitures ​ Acquisition Adjusted |
| Global Industrial | **​** | **$226.9** **​** **-** **​** **$226.9** | ​ | $181.2 ​ - ​ $181.2 |
| Global Institutional |  | **183.5** **​** **(0.6)** **​** **182.9** | ​ | 176.2 ​ - ​ 176.2 |
| Global Healthcare and Life Sciences |  | **25.6** **​** **0.8** **​** **26.4** | ​ | 27.3 ​ - ​ 27.3 |
| Upstream Energy | **​** | **39.0** **​** **-** **​** **39.0** | ​ | 36.5 ​ - ​ 36.5 |
| Other | **​** | **25.3** **​** **-** **​** **25.3** | ​ | 28.9 ​ - ​ 28.9 |
| Corporate |  | **(38.7)** **​** **-** **​** **(38.7)** | ​ | (39.5) ​ - ​ (39.5) |
| Non-GAAP adjusted fixed currency operating income |  | **461.6** **​** **0.2** **​** **461.8** | ​ | 410.6 ​ - ​ 410.6 |
| Special (gains) and charges |  | **61.5** **​** **​** **​** **​** | ​ | 43.9 ​ ​ ​ ​ |
| Subtotal at fixed currency |  | **400.1** **​** **​** **​** **​** | ​ | 366.7 ​ ​ ​ ​ |
| Effect of foreign currency translation |  | **(2.9)** **​** **​** **​** **​** | ​ | 0.5 ​ ​ ​ ​ |
| Total reported operating income |  | **$397.2** **​** **​** **​** **​** | ​ | $367.2 ​ ​ ​ ​ |

Unless otherwise noted, the following segment performance commentary compares the first quarter of 2020 against the first quarter of 2019.

### Global Industrial

| ​ ​ ​ ​ | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ ​ | ​ ​ | ​ 2019 | ​ ​ | ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | --- |
| Sales at fixed currency (millions) | **​** | **​** | **$1,444.0** ​ | ​ | ​ | $1,397.4 ​ | **​** |
| Sales at public currency (millions) | **​** | **​** | **1,434.5** ​ | ​ | ​ | 1,402.0 ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Volume | **​** |  | **1%** | **​** |  | ​ ​ | **​** |
| Price changes | **​** |  | **2%** | **​** |  | ​ ​ | **​** |
| Acquisition adjusted fixed currency sales change | **​** | **​** | **3%** | **​** | ​ | ​ ​ | **​** |
| Acquisitions and divestitures | **​** |  | **-%** | **​** |  | ​ ​ | **​** |
| Fixed currency sales change | **​** |  | **3%** | **​** |  | ​ ​ | **​** |
| Foreign currency translation | **​** | **​** | **(1)%** | **​** | ​ | ​ ​ | **​** |
| Public currency sales change | **​** |  | **2%** | **​** |  | ​ ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Operating income at fixed currency (millions) | **​** | **​** | **$226.9** ​ | ​ | ​ | $181.2 ​ | **​** |
| Operating income at public currency (millions) | **​** | **​** | **225.3** ​ | ​ | ​ | 181.9 ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Fixed currency operating income change | **​** | **​** | **25%** | **​** | ​ | ​ ​ | **​** |
| Fixed currency operating income margin | **​** |  | **15.7%** | **​** |  | 13.0% | **​** |
| Acquisition adjusted fixed currency operating income change | **​** |  | **25%** | **​** |  | ​ ​ | **​** |
| Acquisition adjusted fixed currency operating income margin | **​** |  | **15.7%** | **​** |  | 13.0% | **​** |
| Public currency operating income change | ​ | ​ | **24%** | ​ | ​ | ​ ​ | ​ |
| ​ | ​ | ​ | **​** **​** | ​ | ​ | ​ ​ | ​ |

Percentages in the above table do not necessarily sum due to rounding.

### Net Sales

Fixed currency sales for Global Industrial increased in the first quarter of 2020, benefiting from pricing and volume gains. In the first quarter, all major regions showed sales growth.

At an operating segment level, ***Water*** fixed currency sales increased 1% in the first quarter of 2020. Globally, there were good gains in light industry water treatment, driven by its innovative technology and service offerings. Heavy industry sales declined slightly primarily due to power, where the ongoing conversion to gas fuel from coal hurt sales. Mining declined modestly due to weak coal markets. ***Food & Beverage*** fixed currency sales increased 6% in the first quarter of 2020 led by share gains and pricing. Globally, we saw strong growth in dairy, food and beverage and brewing businesses, and moderate softness in protein. Fixed currency sales grew across all regions. ***Downstream*** fixed currency sales increased 4% in the first quarter of 2020 as sales benefited from steady water treatment volumes and higher additive sales. ***Paper*** fixed currency sales increased 3% in the first quarter of 2020 led by new business and good trends in packaging, tissue and towels.

### Operating Income

Fixed currency operating income and fixed currency operating income margins increased for Global Industrial in the first quarter of 2020.

Acquisition adjusted fixed currency operating income margins increased 2.7 percentage points during the first quarter of 2020 and were positively impacted approximately 3.0 percentage points by pricing, lowered delivered product costs and improved volume gains during the first quarter of 2020.

### Global Institutional

| ​ ​ ​ ​ | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ ​ | ​ ​ | ​ 2019 | ​ ​ | ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | --- |
| Sales at fixed currency (millions) | **​** | **​** | **$1,072.3** ​ | ​ | ​ | $1,020.2 ​ | **​** |
| Sales at public currency (millions) | **​** | **​** | **1,067.2** ​ | ​ | ​ | 1,020.8 ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Volume | **​** |  | **2%** | **​** |  | ​ ​ | **​** |
| Price changes | **​** |  | **2%** | **​** |  | ​ ​ | **​** |
| Acquisition adjusted fixed currency sales change | **​** | **​** | **4%** | **​** | ​ | ​ ​ | **​** |
| Acquisitions and divestitures | **​** |  | **1%** | **​** |  | ​ ​ | **​** |
| Fixed currency sales change | **​** |  | **5%** | **​** |  | ​ ​ | **​** |
| Foreign currency translation | **​** | **​** | **(1)%** | **​** | ​ | ​ ​ | **​** |
| Public currency sales change | **​** |  | **5%** | **​** |  | ​ ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Operating income at fixed currency (millions) | **​** | **​** | **$183.5** ​ | ​ | ​ | $176.2 ​ | **​** |
| Operating income at public currency (millions) | **​** | **​** | **182.8** ​ | ​ | ​ | 176.0 ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Fixed currency operating income change | **​** | **​** | **4%** | **​** | ​ | ​ ​ | **​** |
| Fixed currency operating income margin | **​** |  | **17.1%** | **​** |  | 17.3% | **​** |
| Acquisition adjusted fixed currency operating income change | **​** |  | **4%** | **​** |  | ​ ​ | **​** |
| Acquisition adjusted fixed currency operating income margin | **​** |  | **17.3%** | **​** |  | 17.3% | **​** |
| Public currency operating income change | ​ | ​ | **4%** | ​ | ​ | ​ ​ | ​ |
| ​ | ​ | ​ | **​** **​** | ​ | ​ | ​ ​ | ​ |

Percentages in the above table do not necessarily sum due to rounding.

### Net Sales

Fixed currency sales for Global Institutional increased in the first quarter of 2020, driven by pricing and volume gains. At a regional level, the first quarter fixed currency sales increased in all major regions.

At an operating segment level, ***Institutional*** fixed currency sales increased 1% (0% acquisition adjusted) in the first quarter of 2020 reflecting strong cleaning and sanitizing product sales offset by slowing restaurant, lodging and entertainment facility customer demand due to the pandemic. ***Specialty*** fixed currency sales increased 20% (14% acquisition adjusted) in the first quarter of 2020 led by sharp increases in cleaning and sanitizing product sales.

### Operating Income

Fixed currency operating income increased while fixed currency operating income margins decreased for our Global Institutional segment in the first quarter of 2020.

Acquisition adjusted fixed currency operating income margins remained flat during the first quarter of 2020. Margins were positively impacted approximately 2.7 percentage points from pricing and cost savings initiatives during the first quarter of 2020. Other selling related expenses negatively impacted margins by approximately 2.6 percentage points during the first quarter of 2020.

### Global Healthcare and Life Sciences

| ​ ​ ​ ​ | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ ​ | ​ ​ | ​ 2019 | ​ ​ | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | --- |
| Sales at fixed currency (millions) | **​** | **​** | **$246.2** ​ | ​ | ​ | $227.0 ​ | ​ |
| Sales at public currency (millions) | **​** | **​** | **243.6** ​ | ​ | ​ | 227.6 ​ | ​ |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | ​ |
| Volume | **​** |  | **4%** | **​** |  | ​ ​ | ​ |
| Price changes | **​** |  | **-%** | **​** |  | ​ ​ | ​ |
| Acquisition adjusted fixed currency sales change | **​** | **​** | **4%** | **​** | ​ | ​ ​ | ​ |
| Acquisitions and divestitures | **​** |  | **4%** | **​** |  | ​ ​ | ​ |
| Fixed currency sales change | **​** |  | **8%** | **​** |  | ​ ​ | ​ |
| Foreign currency translation | **​** | **​** | **(1)%** | **​** | ​ | ​ ​ | ​ |
| Public currency sales change | **​** |  | **7%** | **​** |  | ​ ​ | ​ |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | ​ |
| Operating income at fixed currency (millions) | **​** | **​** | **$25.6** ​ | ​ | ​ | $27.3 ​ | ​ |
| Operating income at public currency (millions) | **​** | **​** | **25.2** ​ | ​ | ​ | 27.2 ​ | ​ |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | ​ |
| Fixed currency operating income change | **​** | **​** | **(6)%** | **​** | ​ | ​ ​ | ​ |
| Fixed currency operating income margin | **​** |  | **10.4%** | **​** |  | 12.0% | ​ |
| Acquisition adjusted fixed currency operating income change | **​** |  | **(3)%** | **​** |  | ​ ​ | ​ |
| Acquisition adjusted fixed currency operating income margin | **​** |  | **11.2%** | **​** |  | 12.0% | ​ |
| Public currency operating income change | ​ | ​ | **(7)%** | ​ | ​ | ​ ​ | ​ |
| ​ | ​ | ​ | **​** **​** | ​ | ​ | ​ ​ | ​ |

Percentages in the above table do not necessarily sum due to rounding.

### Net Sales

Fixed currency sales for Global Healthcare and Life Sciences increased in the first quarter of 2020, driven by volume gains. At a regional level, the first quarter fixed currency sales increased in all regions.

At an operating segment level, ***Healthcare*** fixed currency sales increased 6% (2% acquisition adjusted) in the first quarter of 2020, as strong hand and surface disinfection sales growth more than offset the unfavorable effects of the fourth quarter’s product recall in Europe. ***Life Sciences*** fixed currency sales increased 23% (16% acquisition adjusted) in the first quarter of 2020 driven by business wins and pricing in our cleaning and disinfection programs for both the pharmaceutical and personal care markets, and by strong growth in Europe.

### Operating Income

Fixed currency operating income and fixed currency operating income margins for our Global Healthcare and Life Sciences segment decreased in the first quarter of 2020.

Acquisition adjusted fixed currency operating income margins decreased 0.8 percentage points during the first quarter of 2020. Volume gains, which positively impacted margins by approximately 3.9 percentage points during the first quarter of 2020, were more than offset by lower efficiency due to the Healthcare product recall and investments in the business which negatively impacted margins by approximately 4.6 percentage points during the first quarter of 2020.

### Upstream Energy

| ​ ​ ​ ​ | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ ​ | ​ ​ | ​ 2019 | ​ ​ | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | --- |
| Sales at fixed currency (millions) | **​** | **​** | **$562.7** ​ | ​ | ​ | $581.7 ​ | ​ |
| Sales at public currency (millions) | **​** | **​** | **560.4** ​ | ​ | ​ | 580.0 ​ | ​ |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | ​ |
| Volume | **​** |  | **(3)%** | **​** |  | ​ ​ | ​ |
| Price changes | **​** |  | **-%** | **​** |  | ​ ​ | ​ |
| Acquisition adjusted fixed currency sales change | **​** | **​** | **(3)%** | **​** | ​ | ​ ​ | ​ |
| Acquisitions and divestitures | **​** |  | **-%** | **​** |  | ​ ​ | ​ |
| Fixed currency sales change | **​** |  | **(3)%** | **​** |  | ​ ​ | ​ |
| Foreign currency translation | **​** | **​** | **(0)%** | **​** | ​ | ​ ​ | ​ |
| Public currency sales change | **​** |  | **(3)%** | **​** |  | ​ ​ | ​ |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | ​ |
| Operating income at fixed currency (millions) | **​** | **​** | **$39.0** ​ | ​ | ​ | $36.5 ​ | ​ |
| Operating income at public currency (millions) | **​** | **​** | **38.8** ​ | ​ | ​ | 36.5 ​ | ​ |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | ​ |
| Fixed currency operating income change | **​** | **​** | **7%** | **​** | ​ | ​ ​ | ​ |
| Fixed currency operating income margin | **​** |  | **6.9%** | **​** |  | 6.3% | ​ |
| Acquisition adjusted fixed currency operating income change | **​** |  | **7%** | **​** |  | ​ ​ | ​ |
| Acquisition adjusted fixed currency operating income margin | **​** |  | **6.9%** | **​** |  | 6.3% | ​ |
| Public currency operating income change | ​ | ​ | **6%** | ​ | ​ | ​ ​ | ​ |
| ​ | ​ | ​ | **​** **​** | ​ | ​ | ​ ​ | ​ |

Percentages in the above table do not necessarily sum due to rounding.

### Net Sales

Fixed currency sales for Upstream Energy decreased in the first quarter of 2020. A significant decline in the well stimulation business was partially offset by good growth in production sales.

### Operating Income

Fixed currency operating income for Upstream Energy increased during the first quarter of 2020.

Acquisition adjusted fixed currency operating income margins increased 0.6 percentage points during the first quarter of 2020. Cost savings initiatives and improved delivered product costs favorably impacted margins by approximately 3.4 percentage points during the first quarter of 2020. These gains more than offset a negative impact of approximately 2.6 percentage points related to lower sales volume leverage and investments in the business during the first quarter of 2020.

### Other

| ​ ​ ​ ​ | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ ​ | ​ ​ | ​ 2019 | ​ ​ | ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | --- |
| Sales at fixed currency (millions) | **​** | **​** | **$277.8** ​ | ​ | ​ | $274.7 ​ | **​** |
| Sales at public currency (millions) | **​** | **​** | **275.7** ​ | ​ | ​ | 275.0 ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Volume | **​** |  | **(1)%** | **​** |  | ​ ​ | **​** |
| Price changes | **​** |  | **2%** | **​** |  | ​ ​ | **​** |
| Acquisition adjusted fixed currency sales change | **​** | **​** | **1%** | **​** | ​ | ​ ​ | **​** |
| Acquisitions and divestitures | **​** |  | **0%** | **​** |  | ​ ​ | **​** |
| Fixed currency sales change | **​** |  | **1%** | **​** |  | ​ ​ | **​** |
| Foreign currency translation | **​** | **​** | **(1)%** | **​** | ​ | ​ ​ | **​** |
| Public currency sales change | **​** |  | **0%** | **​** |  | ​ ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Operating income at fixed currency (millions) | **​** | **​** | **$25.3** ​ | ​ | ​ | $28.9 ​ | **​** |
| Operating income at public currency (millions) | **​** | **​** | **25.2** ​ | ​ | ​ | 29.1 ​ | **​** |
| ​ | **​** | **​** | **​** ​ | ​ | ​ | ​ ​ | **​** |
| Fixed currency operating income change | **​** | **​** | **(12)%** | **​** | ​ | ​ ​ | **​** |
| Fixed currency operating income margin | **​** |  | **9.1%** | **​** |  | 10.5% | **​** |
| Acquisition adjusted fixed currency operating income change | **​** |  | **(12)%** | **​** |  | ​ ​ | **​** |
| Acquisition adjusted fixed currency operating income margin | **​** |  | **9.1%** | **​** |  | 10.5% | **​** |
| Public currency operating income change | ​ | ​ | **(13)%** | ​ | ​ | ​ ​ | ​ |
| ​ | ​ | ​ | **​** **​** | ​ | ​ | ​ ​ | ​ |

Percentages in the above table do not necessarily sum due to rounding.

### Net Sales

Fixed currency sales for Other increased in the first quarter of 2020 with modest gains in Pest Elimination. At a regional level, the first quarter of 2020 sales results showed growth across all major regions.

At an operating segment level, ***Pest Elimination*** fixed currency sales increased 2% in the first quarter of 2020 with sales growth in all major regions. Sales results reflect the negative impacts of COVID-19 primarily on China and North America sales in the quarter, where customer closures limited access for normal service. ***Colloidal Technologies Group*** fixed currency sales decreased 1% in the first quarter of 2020. ***Textile Care*** fixed currency sales decreased 1% in the first quarter of 2020.

### Operating Income

Acquisition adjusted fixed currency operating income margins for Other decreased 1.4 percentage points during the first quarter of 2020. Reduced productivity on lower sales growth negatively impacted margins by approximately 2.6 percentage points for the first quarter of 2020. These costs were partially offset by improved pricing which positively impacted margins by approximately 1.5 percentage points for the first quarter of 2020.

### Corporate

Consistent with our internal management reporting, Corporate amounts in the table on page 39 include intangible asset amortization specifically from the Nalco merger and special (gains) and charges that are not allocated to our reportable segments. Items included within special (gains) and charges are shown in the table on page 35.

### FINANCIAL POSITION, CASH FLOWS AND LIQUIDITY

### Financial Position

Total assets were $22.4 billion as of March 31, 2020 compared to total assets of $20.9 billion as of December 31, 2019.

Total liabilities were $13.5 billion as of March 31, 2020 compared to total liabilities of $12.1 billion as of December 31, 2019. Total debt was $7.8 billion as of March 31, 2020 and $6.4 billion as of December 31, 2019. See further discussion of our debt activity within the “Liquidity and Capital Resources” section of this MD&A.

Our net debt to earnings before interest, taxes, depreciation and amortization (“EBITDA”) is shown in the following table. EBITDA is a non-GAAP measures discussed further in the “Non-GAAP Financial Measures” section of this MD&A.

The inputs to EBITDA reflect the trailing twelve months of activity for the period presented.

| ​ ​ (ratio) | ​ ​ | ​ 2020 ​ | ​ ​ | ​ ​ | ​ ​ | ​ 2019 ​ | ​ ​ | ​ ​ | ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- |
| Net debt to EBITDA |  | **​** | **2.0** | **​** |  | ​ | 2.1 | ​ |  |
| ​ | **​** | **​** | **​** | **​** | ​ | ​ | ​ | ​ | **​** |
| (millions) |  | **​** | **​** | **​** | ​ | ​ | ​ | ​ |  |
| Total debt | **​** | **​** | **$7,782.3** | **​** | ​ | ​ | $6,354.1 | ​ | **​** |
| Cash | **​** |  | **1,661.9** | **​** | ​ | ​ | 186.4 | ​ | **​** |
| Net debt | **​** | **​** | **$6,120.4** | **​** | ​ | ​ | $6,167.7 | ​ | **​** |
| ​ | **​** | **​** | **​** | **​** | ​ | ​ | ​ | ​ | **​** |
| Net income including noncontrolling interest | ​ | **​** | **$1,566.0** | **​** | ​ | ​ | $1,492.5 | ​ | ​ |
| Provision for income taxes | **​** |  | **358.2** | **​** | ​ | ​ | 333.8 | ​ | **​** |
| Interest expense, net | **​** |  | **189.9** | **​** | ​ | ​ | 215.3 | ​ | **​** |
| Depreciation | **​** |  | **664.4** | **​** | ​ | ​ | 629.4 | ​ | **​** |
| Amortization | **​** |  | **319.7** | **​** | ​ | ​ | 316.6 | ​ | **​** |
| EBITDA | **​** |  | **$3,098.2** | **​** | ​ | ​ | $2,987.6 | ​ | **​** |
| ​ | **​** | **​** | **​** | **​** | ​ | ​ | ​ | ​ | **​** |

### Cash Flows

### Operating Activities

| ​ ​ ​ (millions) | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ ​ | ​ 2019 | ​ | ​ | ​ | ​ Change | ​ | ​ | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- |
| Cash provided by operating activities | ​ | **​** | **$371.8** | ​ | ​ | ​ | $378.1 | ​ | ​ | **​** | **$(6.3)** | **​** | **​** |

We continue to generate strong cash flow from operations, allowing us to fund our ongoing operations, acquisitions, investments in the business and pension obligations along with returning cash to our shareholders through dividend payments and share repurchases.

Comparability of cash generated from operating activities was impacted by fluctuations in accounts receivable, inventories and accounts payable (“working capital”). The cash flow impact from working capital accounts was driven by timing of collections and sales volume along with production usage levels.

### Investing Activities

| ​ ​ ​ (millions) | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ ​ | ​ 2019 | ​ | ​ | ​ | ​ Change | ​ | ​ | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- |
| Cash used for investing activities | ​ | **​** | **$(165.7)** | ​ | ​ | ​ | $(477.4) | ​ | ​ | **​** | **$311.7** | **​** | **​** |

Cash used for investing activities is primarily impacted by the timing of business acquisitions and dispositions as well as capital investments in the business.

Total cash paid for acquisitions, net of cash acquired and net of cash received from dispositions, during the first quarter in 2020 and 2019, was $2 million and $282 million, respectively. Our acquisitions and divestitures are discussed further in Note 3. We continue to target strategic business acquisitions which complement our growth strategy and expect to continue to make capital investments and acquisitions in the future to support our long-term growth.

We continue to make capital investments in the business, including merchandising and customer equipment and manufacturing facilities. Total capital expenditures were $161 million and $187 million in the first quarter of 2020 and 2019, respectively.

### Financing Activities

| ​ ​ ​ (millions) | ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ ​ | ​ 2019 | ​ | ​ | ​ | ​ Change | ​ | ​ | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- |
| Cash provided by (used for) financing activities | ​ | **​** | **$1,265.8** | ​ | ​ | ​ | $(117.5) | ​ | ​ | **​** | **$1,383.3** | **​** | **​** |

Our cash flows from financing activities primarily reflect the issuances and repayment of debt, common stock repurchases, proceeds from common stock issuances related to our equity incentive programs and dividend payments.

We issued $767 million of long-term debt in the first quarter of 2020. We repaid $300 million and $400 million of long-term debt in the first quarter of 2020 and 2019, respectively. The proceeds received from the debt issuances will be used for repayment of commercial paper and general corporate purposes. In addition, we had net issuances of commercial paper of $958 million and $488 million in the first quarter of 2020 and 2019, respectively.

Shares are repurchased for the purpose of partially offsetting the dilutive effect of our equity compensation plans and stock issued in acquisitions, to manage our capital structure and to efficiently return capital to shareholders. We repurchased a total of $95 million and $131 million of shares in the first quarter of 2020 and 2019, respectively. Cash proceeds and tax benefits from stock option exercises provide a portion of the funding for repurchase activity.

The impact on financing cash flows of commercial paper and notes payable issuances and long-term debt borrowings and repayments are shown in the following table:

| ​ ​ ​ (millions) | ​ ​ ​ ​ | ​ First Quarter Ended March 31 2020 | ​ | ​ | ​ ​ | ​ 2019 | ​ | ​ | ​ | ​ Change | ​ | ​ | ​ ​ ​ ​ |
| --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- | --- | ---: | --- | --- |
| Net issuances (repayments) of commercial paper and notes payable | **​** | **​** | **$957.6** | ​ | ​ | ​ | $487.9 | ​ | ​ | **​** | **$469.7** | ​ | ​ |
| Long-term debt borrowings | **​** | **​** | **766.6** | ​ | ​ | ​ | - | ​ | ​ | **​** | **766.6** | ​ | ​ |
| Long-term debt repayments | **​** | **​** | **(299.7)** | ​ | ​ | ​ | (400.3) | ​ | ​ | **​** | **100.6** | ​ | ​ |

### Liquidity and Capital Resources

We currently expect to fund the cash requirements which are reasonably foreseeable for the next twelve months, including scheduled debt repayments, new investments in the business, share repurchases, dividend payments, possible business acquisitions and pension and postretirement contributions with cash from operating activities, and as needed, additional short-term and/or long-term borrowings. We continue to expect our operating cash flow to remain strong.

As of March 31, 2020, we had $1,662 million of cash and cash equivalents on hand, of which $208 million was held outside of the U.S.

As of March 31, 2020, we have a $2.0 billion multi-year credit facility which expires in November 2022. The credit facility has been established with a diverse syndicate of banks and supports our U.S. and Euro commercial paper programs. The maximum aggregate amount of commercial paper that may be issued under our U.S. commercial paper program and our Euro commercial paper program may not exceed $2.0 billion. At the end of the first quarter of 2020, we had $298 million (€270 million) of commercial paper outstanding under our Euro program and $703 million outstanding under our U.S. program. There were no borrowings under our credit facility as of March 31, 2020 or 2019. As of March 31, 2020, both programs were rated A-2 by Standard & Poor’s, P-2 by Moody’s and F-1 by Fitch.

In April 2020, we executed a $500 million 364-day revolving credit agreement to be used for general corporate purposes with a diverse syndicate of banks to provide for further liquidity over the next twelve months in response to the coronavirus pandemic. In addition, we executed and have drawn on a $305 million term credit agreement to be repaid in the second quarter of 2020.

Our long-term debt issuance and repayment activity through the first three months of 2020 and 2019 is discussed in the Cash Flows – Financing Activities section of this MD&A.

We are in compliance with our debt covenants and believe we have sufficient borrowing capacity to meet our foreseeable operating activities, as needed.

The schedule of contractual obligations included in the Financial Position and Liquidity section of our Form 10-K for the year ended December 31, 2019 disclosed total notes payable and long-term debt due within one year of $326 million. As of March 31, 2020, the total notes payable and long-term debt due within one year decreased to $37 million. The commercial paper outstanding as of March 31, 2020 increased to $1,001 million. The commercial paper outstanding as of December 31, 2019 was $55 million.

Our gross liability for uncertain tax positions was $25 million as of March 31, 2020 and $28 million as of December 31, 2019. We are not able to reasonably estimate the amount by which the liability will increase or decrease over time; however, at this time, we do not expect significant payments related to these obligations within the next year.

### GLOBAL ECONOMIC ENVIRONMENT

### Energy Markets

The oil and gas industry is cyclical in nature and experiences periodic downturns of varying length and severity. The oil and gas industry experienced a significant downturn in 2015 and 2016 as a result of a sharp decline in crude oil prices. Crude oil price volatility continued through 2019 and, partially due to the emergence of the COVID-19 pandemic and failure of the Organization of the Petroleum Exporting Countries (“OPEC”) and other major producers to agree on production cuts, has become more extreme in 2020. Demand for our products and services is sensitive to the level of capital spending by oil and natural gas companies and the corresponding drilling and production activity. The level of drilling and production activity and refining and petrochemical processing are directly affected by trends in crude oil and natural gas prices, which are influenced by numerous factors affecting the supply and demand for oil and gas, many of which are beyond our control. Approximately 16% of total Ecolab sales are generated from our Upstream Energy segment, the results of which are subject to changes in the oil and gas commodity markets.

### Coronavirus disease 2019 (COVID-19)

In March 2020, the coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization. The COVID-19 pandemic is affecting major economic and financial markets, while industries are facing the challenges with the economic conditions resulting from efforts to address the pandemic. As the spread of the pandemic increases, many countries have required companies to limit or suspend business operations and have implemented travel restrictions. These conditions have had and will continue to have a negative impact on market conditions and customer demand throughout the world. We anticipate adverse impacts and disruptions in our restaurant, lodging and entertainment-related business operations, with limited or no adverse impacts on certain other parts of our business, supply chain and business continuity plans from COVID-19 restrictions; certain of our business will benefit from increased cleanings and sanitizing product demand. The ongoing effects of the global COVID-19 outbreak and reduction in oil prices to current levels could result in a global recession.

We anticipate a reduction to our 2020 results of operations and operating cash flows due to lower market demand, but we are not yet able to estimate the full impact of the coronavirus outbreak as it continues to spread globally. While we continue to provide cleaning, disinfection programs and increased sanitizing protocols in response to the pandemic in healthcare, quick-service and food and beverage plant customers, we anticipate products and services provided to the full-service restaurant, hospitality, lodging and entertainment industries will decline in the upcoming quarter due to the regulatory and organizational mandates that have been put in place. We have taken, and are continuing to take, steps to reduce costs, including reductions in capital expenditures, as well as other ongoing cost initiatives.

### Global Economies

Approximately half of our sales are outside of the U.S. Our international operations subject us to changes in economic conditions and foreign currency exchange rates as well as political uncertainty in some countries which could impact future operating results.

Argentina has continued to experience negative economic trends, evidenced by multiple periods of increasing inflation rates, devaluation of the peso, and increasing borrowing rates. Argentina is classified as a highly inflationary economy in accordance with U.S. GAAP, and the U.S. dollar is the functional currency for our subsidiaries in Argentina. During the first quarter of 2020, sales in Argentina represented less than 1% of our consolidated sales. Assets held in Argentina at the end of the first quarter represented less than 1% of our consolidated assets.

### Brexit Referendum

Effective January 31, 2020, the U.K. left the European Union. The U.K.’s relationship with the EU will no longer be governed by the EU Treaties, but instead by the terms of the Withdrawal Agreement agreed between the U.K. and the EU in late 2019. The Withdrawal Agreement provides for a “transition” period, which commenced the moment the U.K. left the EU and is currently set to end on December 31, 2020. At the end of the transition period, there may be significant changes to the U.K.’s business environment. While the effects of Brexit will depend on any agreements the U.K. makes to retain access to EU markets or the failure to reach such agreements, the uncertainties created by Brexit, any resolution between the U.K. and EU countries or the failure to reach any such resolutions, could adversely affect our relationships with customers, suppliers and employees and could adversely affect our business.

### NEW ACCOUNTING PRONOUNCEMENTS

For information on new accounting pronouncements, refer to Note 17 to the Consolidated Financial Statements.

### SUBSEQUENT EVENTS

During the first quarter of 2020, we reached an agreement to purchase CID Lines, a leading global provider of livestock biosecurity and hygiene solutions. The acquisition is expected to close in the second quarter of 2020 and is subject to various regulatory clearances.

In April 2020, we executed a $500 million 364-day revolving credit agreement to be used for general corporate purposes with a diverse syndicate of banks. In addition, we executed and have drawn on a $305 million term credit agreement to be repaid in the second quarter of 2020.

### NON-GAAP FINANCIAL MEASURES

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operation” in Item 2, contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). These non-GAAP measures include:

- Fixed currency sales
- Acquisition adjusted fixed currency sales
- Adjusted cost of sales
- Adjusted gross margin
- Fixed currency operating income
- Fixed currency operating income margin
- Adjusted operating income
- Adjusted operating income margin
- Adjusted fixed currency operating income
- Adjusted fixed currency operating income margin
- Acquisition adjusted fixed currency operating income
- Acquisition adjusted fixed currency operating income margin
- Adjusted interest expense, net
- EBITDA
- Adjusted tax rate
- Adjusted net income attributable to Ecolab
- Adjusted diluted EPS

We provide these measures as additional information regarding our operating results. We use these non-GAAP measures internally to evaluate our performance and in making financial and operational decisions, including with respect to incentive compensation. We believe that our presentation of these measures provides investors with greater transparency with respect to our results of operations and that these measures are useful for period-to-period comparison of results.

Our non-GAAP financial measures for cost of sales, gross margin and operating income exclude the impact of special (gains) and charges, and our non-GAAP measures for tax rate, net income attributable to Ecolab and diluted EPS further exclude the impact of discrete tax items. We include items within special (gains) and charges and discrete tax items that we believe can significantly affect the period-over-period assessment of operating results and not necessarily reflect costs and/or income associated with historical trends and future results. After tax special (gains) and charges are derived by applying the applicable local jurisdictional tax rate to the corresponding pre-tax special (gains) and charges.

EBITDA is defined as the sum of net income including noncontrolling interest, provision for income taxes, net interest expense, depreciation and amortization. EBITDA is used in our net debt to EBITDA ratio, which we view as important indicators of the operational and financial health of our organization.

We evaluate the performance of our international operations based on fixed currency rates of foreign exchange. Fixed currency amounts included in this Form 10-Q are based on translation into U.S. dollars at the fixed foreign currency exchange rates established by management at the beginning of 2020.

Acquisition adjusted growth rates exclude the results of our acquired businesses from the first twelve months post acquisition, exclude the results of our divested businesses from the twelve months prior to divestiture.

These non-GAAP measures are not in accordance with, or an alternative to U.S. GAAP, and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend that investors view these measures in conjunction with the U.S. GAAP measures included in this MD&A and we have provided reconciliations of reported U.S. GAAP amounts to the non-GAAP amounts.

### FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include the effects of the COVID-19 pandemic, anticipated separation of our Upstream Energy business into a new stand-alone company and the expected form, timing and tax effects thereof and the subsequent merger of the Upstream Energy business with Apergy Corporation; expectations concerning timing, amount and type of restructuring costs and savings from restructuring activities; tax deductibility of goodwill; capital investments and acquisitions; amortization expense; non-performance of financial counterparties; payments and contributions to pension and postretirement health care benefit plans; impact of tax reform; the impact of lawsuits, claims and environmental matters; impact of new accounting pronouncements; cash flows, borrowing capacity and funding of cash requirements; payments related to uncertain tax positions; impact of oil price fluctuations, on the demand for the products and services of our Upstream Energy business; implementation of ERP system upgrade; and doing business relating to Iran.

Without limiting the foregoing, words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “we expect,” “estimate,” “project” (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements. Forward-looking statements may also represent challenging goals for us. These statements, which represent our expectations or beliefs concerning various future events, are based on current expectations that involve a number of risks and uncertainties that could cause actual results to differ materially from those of such forward-looking statements. In particular, the effects of the COVID-19 pandemic depend on the duration of the outbreak, government response to the outbreak, the success of mitigation strategies, the ability of our customers to ramp up operations and the frequency of additional outbreaks; the proposed separation and merger of the Upstream Energy business with Apergy Corporation may not be consummated within the anticipated period or at all; and the ultimate results of any restructuring and business improvement actions, including cost synergies, depend on a number of factors, including the development of final plans, the impact of local regulatory requirements regarding employee terminations, the time necessary to develop and implement the restructuring and other business improvement initiatives and the level of success achieved through such actions in improving competitiveness, efficiency and effectiveness. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made.

Some of the factors which could cause results to differ materially from those expressed in any forward-looking statements are set forth under Item 1A of our most recent Form 10-K, and our other public filings with the Securities and Exchange Commission (the "SEC"), and include the effects of the coronavirus (COVID-19) pandemic; the vitality of the markets we serve, including the impact of oil and natural gas price fluctuations and duration on the profitability and financial stability of the customers of our businesses serving the upstream and downstream oil and gas industry; the impact of economic factors such as the worldwide economy, capital flows, interest rates, foreign currency risk and reduced sales and earnings in our international operations resulting from the weakening of local currencies versus the U.S. dollar; our ability to execute key business initiatives, including restructurings and our Enterprise Resource Planning system upgrades; potential information technology infrastructure failures or breaches in data security; our ability to achieve the intended benefits of our plan to separate our Upstream Energy business and combine it with Apergy Corporation; our ability to attract, retain and develop high caliber management talent to lead our business; our ability to successfully compete with respect to value, innovation and customer support; exposure to global economic, political and legal risks related to our international operations; difficulty in procuring raw materials or fluctuations in raw material costs; pressure on operations from consolidation of customers or vendors; the costs and effects of complying with laws and regulations, including those relating to the environment, to the manufacture, storage, distribution, sale and use of our products and to labor and employment, as well as to the conduct of our business generally; the occurrence of litigation or claims, including the pending lawsuits against certain of our subsidiaries related to the Deepwater Horizon oil spill or class action lawsuits; restraints on pricing flexibility due to contractual obligations; our ability to acquire complementary businesses and to effectively integrate such businesses; changes in tax laws and unanticipated tax liabilities; potential loss of deferred tax assets; our indebtedness, and any failure to comply with the covenants that apply to our indebtedness; public health outbreaks, epidemics or pandemics, such as the current outbreak of COVID-19; potential losses arising from the impairment of goodwill or other assets; potential chemical spill or release; the loss or insolvency of a major customer or distributor; repeated or prolonged government and/or business shutdowns or similar events; acts of war or terrorism; natural or man-made disasters; water shortages; severe weather conditions; and other uncertainties or risks reported from time to time in our reports to the SEC. There can be no assurances that our earnings levels will meet investors’ expectations. Except as may be required under applicable law, we do not undertake, and expressly disclaim, any duty to update our Forward-Looking Statements.

## Market risk

As filed, 555 characters.

We use foreign currency forward contracts, interest rate swap agreements and foreign currency debt to manage risks associated with foreign currency exchange rates, interest rates and net investments in our foreign operations. We do not hold derivative financial instruments of a speculative nature or for trading purposes. For a more detailed discussion of derivative instruments, refer to Note 8, entitled “Derivatives and Hedging Transactions”, of the consolidated financial statements located under Part I, Item 1 of this quarterly report on Form 10-Q.

## Controls and procedures

As filed, 1,346 characters.

As of March 31, 2020, we carried out an evaluation, under the supervision and with the participation of our management, including the Chairman of the Board and Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chairman of the Board and Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures are effective.

During the period January 1 through March 31, 2020, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We are continuing our implementation of our enterprise resource planning (“ERP”) system upgrades, which are expected to occur in phases over the next several years. These upgrades, which include supply chain and certain finance functions, are expected to improve the efficiency of certain financial and related transactional processes. We are also making changes to our system in order to support our separation of the ChampionX business. These upgrades of the ERP systems will affect the processes that constitute our internal control over financial reporting and will require testing for effectiveness.

## Risk factors

As filed, 5,998 characters.

In our report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on February 28, 2020, we identify under Item 1A important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from our anticipated results or other expectations, including those expressed in any forward-looking statements made in this Form 10-Q. See the section entitled Forward-Looking Statements located on page 50 of this Form 10-Q. We may also refer to such disclosure to identify factors that may cause results to differ from those expressed in other forward-looking statements made in oral presentations, including telephone conferences and/or webcasts open to the public.

The discussion below provides updates and additions to the risk factors and should be read together with the full list of risk factors set forth in the aforementioned Form 10-K.

***Severe public health outbreaks, epidemics or pandemics, such as coronavirus (COVID-19), may materially and adversely impact our business.***

Our business could be materially and adversely affected by the effect of a public health outbreak, epidemic or pandemic. The United States and other countries have experienced, and may experience in the future, public health outbreaks such as COVID-19, Zika virus, Avian Flu, SARS and H1N1 influenza. A prolonged occurrence of a contagious disease such as these could result in a significant downturn in the foodservice, hospitality, energy and travel industries, or economies generally, and also may result in health or other government authorities imposing restrictions on travel further impacting our end markets. Any of these events could result in a significant drop in demand for some of our products and services and materially and adversely affect our business.

In December 2019, a novel strain of coronavirus, which causes COVID-19, emerged in Wuhan, Hubei Province, China. While initially the COVID-19 outbreak was largely concentrated in China and caused significant disruptions to its economy and businesses elsewhere with significant supply chain relationships with China, it has now spread to many other countries, and infections have been reported globally, including in the United States. Government actions to reduce novel coronavirus transmissions by limiting social interactions have significantly impacted our restaurant and hospitality customers, negatively affecting demand for our products in these segments. The extent of the negative impact of the COVID-19 pandemic on our results of operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the economic impact and the duration of the outbreak, new information that may emerge concerning the severity of COVID-19 and the actions to contain the novel coronavirus or treat its impact, among others. The novel coronavirus has had a negative impact on market conditions and customer demand, particularly from our restaurant and hospitality industry customers, and could adversely affect our supply chain as a result of, among other factors, energy price volatility. We anticipate that the slowdown in business activity in our end markets as a result of the COVID-19 pandemic will negatively impact our results of operations, but we are not yet able to estimate the extent of the negative impact on our results of operations due to the pandemic's rapidly evolving and expanding effects and government actions to control its transmission.

***Trends in crude oil and natural gas prices may affect the profitability and financial stability of the customers of our businesses serving the upstream and downstream oil and gas industry and therefore the demand for, and profitability of our products and services, which could have a material adverse effect on our business, results of operations and financial condition.***

The oil and gas industry is cyclical in nature and experiences periodic downturns of varying length and severity. The oil and gas industry experienced a significant downturn in 2015 and 2016 as a result of a sharp decline in crude oil prices. Crude oil prices slightly recovered in late 2016 and into 2017 but experienced a volatile decline again during late 2018. Price volatility continued throughout 2019 and, partially due to the emergence of the COVID-19 pandemic and failure of the Organization of the Petroleum Exporting Countries (“OPEC”) and other major producers to agree on production cuts, has become more extreme in 2020. Demand for our products and services is sensitive to the level of capital spending by oil and natural gas companies and the corresponding drilling and production activity. The level of drilling and production activity and refining and petrochemical processing are directly affected by trends in crude oil and natural gas prices, which are influenced by numerous factors affecting the supply and demand for oil and gas, many of which are beyond our control. For example, in March 2020, members of OPEC and Russia considered extending their previously agreed oil production cuts and potentially making additional oil production cuts. However, these negotiations were unsuccessful. As a result, Saudi Arabia announced a significant reduction in its export prices and Russia announced the expiration of all agreed oil production cuts between members of OPEC and Russia. Following these announcements, and also as a result of the increased global scale and severity of the COVID-19 outbreak during this period, global oil and natural gas prices declined sharply. While a deal to cut production has since been announced by OPEC and its allies, the situation has resulted in a significant downturn in the industry. Such a downturn could result in the reduction in demand for our products and services and could have a material adverse effect on our business, results of operations, financial condition and cash flows.

Filed May 7, 2020.
Source: SEC EDGAR, the filing index for accession 0001558370-20-005691. Last ingested by Listed: Nov 13, 2026, 16:24 ET. No prices; not investment advice.
